Skip to main content
Kaisa Group Holdings Ltd. logo

Kaisa Group Holdings Ltd. — Investor Relations & Filings

Ticker · 1638 ISIN · KYG521321003 LEI · 254900N8L3L7NRJT0120 HKEX Real estate activities
Open in API
Filings indexed 1,130 across all filing types
Latest filing 2018-01-18 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 1638

About Kaisa Group Holdings Ltd.

http://www.kaisagroup.com

Kaisa Group Holdings Ltd. is a large-scale integrated investment group specializing in urban development and operation. Its core business involves comprehensive real estate development, including residential communities, office buildings, large urban complexes, and industrial properties. A central strategic focus is urban renewal and redevelopment, where the Group is recognized for its expertise in transforming older urban areas. Kaisa operates across key economic regions, including the Guangdong-Hong Kong-Macao Greater Bay Area, the Yangtze River Economic Belt, and the Beijing-Tianjin-Hebei region. The Group maintains a diversified portfolio spanning ten sectors, which include property management, health and medical services, culture, sports, and technology operations, commercial asset management, tourism and international parks, hotel operations, maritime transportation, and international education services.

Recent filings

Filing Released Lang Actions
(1) RESIGNATION OF EXECUTIVE DIRECTOR (2) CHANGE OF AUTHORISED REPRESENTATIVE
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an executive director and the appointment of a new authorised representative. It references compliance with the Listing Rules of the Hong Kong Stock Exchange and provides details about changes in the company's board members. There is no financial data, report, or presentation included. The content fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2018-01-18 English
SUPPLEMENTAL AGREEMENT IN RELATION TO THE ACQUISITION OF APPROXIMATELY 18.57% IN ZHENXING BIOPHARMACEUTICAL & CHEMICAL CO., LTD
Capital/Financing Update Classification · 95% confidence The document is an announcement from Kaisa Group Holdings Ltd. regarding a supplemental agreement related to an acquisition. It references a previous announcement and details changes to payment conditions in the acquisition agreement. The document is relatively short (2725 characters) and does not contain financial statements or detailed financial analysis. It is clearly an update on a capital transaction rather than a full report or financial disclosure. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2018-01-16 English
SUPPLEMENTAL AGREEMENT IN RELATION TO THE ACQUISITION OF APPROXIMATELY 18.57% IN ZHENXING BIOPHARMACEUTICAL & CHEMICAL CO., LTD
Capital/Financing Update Classification · 95% confidence The document is an announcement from Kaisa Group Holdings Ltd. regarding a supplemental agreement related to an acquisition of approximately 18.57% in Zhenxing Biopharmaceutical & Chemical Co., Ltd. It references a previous announcement dated 28 November 2017 and details changes to payment conditions under the acquisition agreement. The document is relatively short (2725 characters) and focuses on updating shareholders and the market about a change in terms of an acquisition agreement, not providing full financial data or detailed financial analysis. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. It is not a full report, earnings release, or regulatory filing, but a specific update on a financing-related transaction.
2018-01-15 English
UNAUDITED OPERATING FIGURES FOR THE YEAR ENDED 31 DECEMBER 2017
Capital/Financing Update Classification · 85% confidence The document is an announcement by Kaisa Group Holdings Ltd. disclosing unaudited operating figures for the year ended 31 December 2017. It explicitly states that the figures are preliminary, unaudited, and based on internal information, and cautions investors not to rely on them as definitive financial performance. The document is relatively short (3350 characters) and serves as an update on operating figures rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Annual Report (10-K) or Interim Report (IR). It also does not fit categories like Earnings Release (ER) because it is not a formal earnings announcement, nor is it a Regulatory Filing (RNS) or Report Publication Announcement (RPA) since it provides substantive preliminary data rather than just announcing a report's release. The best fit is Capital/Financing Update (CAP) as it provides updated operating figures relevant to investors and the market, consistent with voluntary disclosure under listing rules.
2018-01-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 December 2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There is no indication of financial performance data, earnings, management discussion, or regulatory certifications. The document is a periodic report on share capital movements, which aligns with announcements regarding share issues or capital changes rather than a full financial report or other categories. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support a high confidence in this classification.
2018-01-04 English
FURTHER ANNOUNCEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement from Kaisa Group Holdings Ltd. providing further information related to a previously announced acquisition of approximately 18.57% of Zhenxing Biopharmaceutical & Chemical Co., Ltd. It references prior announcements and clarifies details about the acquisition consideration and funding. The document is relatively short (3023 characters) and serves as an update or supplement to earlier announcements rather than a full report or detailed financial disclosure. It does not contain financial statements, management discussion, or detailed financial data. It is clearly an announcement related to capital acquisition activity, specifically providing further details on a financing-related transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2017-12-19 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.